Reported May 28, 2025 · Ongoing
Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation…
AsttraZeneca Pharmaceuticals LP
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: AsttraZeneca Pharmaceuticals LP · 1800 Concord Pike · Wilmington, DE · 19897-0001
Is this the product you have?
- Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only
- Manufactured forAstraZeneca Pharmaceuticals LP, Wilmington, DE 19850
- ByAstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France
- Lot codes and dates
Lot#: a) 6270044C006270040D006270034E00Exp Date 10/20266270053C006270045C006270047C006270056C006270052C006270063E00 Exp 11/30/20266270064C006270071D006270075D006270075F00 Exp Date 12/31/20266270107C00Exp Date 9/30/2027b) Lot 6270019E00Exp Date 7/31/20256270021D00Exp 8/31/20256270095C00Exp 2/28/2026
- Amount recalled
- a) 807,837 canisters; b) 235,698 canisters
Where it was sold
- Nationwide
Why it was recalled
Defective delivery system
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new AsttraZeneca Pharmaceuticals LP recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.